Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients

NCT04446416 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme
Glioblastoma
Glioma
Brain Tumor
Neoplasms
Neoplasms, Nerve Tissue

Interventions

DEVICE: NaviFUS System
DRUG: Bevacizumab

Sponsor

NaviFUS Corporation

Collaborators

[object Object]